{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T17:56:25Z","timestamp":1761155785614,"version":"3.44.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.ahj.2014.04.009","type":"journal-article","created":{"date-parts":[[2014,4,24]],"date-time":"2014-04-24T03:45:50Z","timestamp":1398311150000},"page":"182-188.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Association of metabolic syndrome and its individual components with outcomes among patients with high-risk non\u2013ST-segment elevation acute coronary syndromes"],"prefix":"10.1016","volume":"168","author":[{"given":"Rajendra H.","family":"Mehta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia M.","family":"Westerhout","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinggan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert P.","family":"Giugliano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kurt","family":"Huber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorairaj","family":"Prabhakaran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert A.","family":"Harrington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristin L.","family":"Newby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul W.","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2014.04.009_bb0005","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","article-title":"Diagnosis and management of metabolic syndrome: an American Heart Association\/National Heart Blood and Lung Institute scientific statement","volume":"112","author":"Grundy","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2014.04.009_bb0010","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1093\/aje\/kwf145","article-title":"Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of metabolic syndrome in prospective cohort study","volume":"156","author":"Laaksonen","year":"2002","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ahj.2014.04.009_bb0015","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.2337\/diacare.27.11.2676","article-title":"Does the metabolic syndrome improve the identification of individuals at risk of type 2 diabetes and\/or cardiovascular disease?","volume":"27","author":"Stern","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ahj.2014.04.009_bb0020","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11892-004-0013-9","article-title":"Cardiovascular risk associated with metabolic syndrome","volume":"4","author":"Lindsay","year":"2004","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.ahj.2014.04.009_bb0025","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.jacc.2010.05.034","article-title":"The metabolic syndrome and cardiovascular risk\u2014a systematic review and meta-analysis","volume":"56","author":"Mottillo","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2014.04.009_bb0030","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1161\/CIR.0b013e3182456d46","article-title":"Update: executive summary\u2014Heart Disease and Stroke Statistics\u20142012 update. A report from the American Heart Association","volume":"125","author":"Statistical","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2014.04.009_bb0035","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1253\/circj.CJ-08-1122","article-title":"Impact of metabolic syndrome on 10-year clinical outcomes in patients with acute coronary syndromes","volume":"73","author":"Dohi","year":"2009","journal-title":"Circ J"},{"key":"10.1016\/j.ahj.2014.04.009_bb0040","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/j.amjcard.2006.07.025","article-title":"Prevalence of metabolic syndrome after acute coronary syndrome and its prognostic significance","volume":"98","author":"Boulon","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2014.04.009_bb0045","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.2337\/diacare.28.10.2508","article-title":"Relation of characteristics of metabolic syndrome to short-term prognosis and effects of intensive statin therapy after acute coronary syndrome. An Analysis of the Myocardial Infarction Reduction With Aggressive Cholesterol Lowering (MIRACL) trial","volume":"28","author":"Schwartz","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ahj.2014.04.009_bb0050","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jacc.2005.03.062","article-title":"Metabolic syndrome and the risk of cardiovascular events after acute myocardial infarction","volume":"46","author":"Levantasi","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2014.04.009_bb0055","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1016\/j.jacc.2009.12.053","article-title":"Metabolic syndrome and risk of acute myocardial infarction. A case-control study of 26,903 subjects from 52 countries","volume":"55","author":"Mente","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2014.04.009_bb0060","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.amjcard.2003.09.032","article-title":"Effect of increasing metabolic syndrome score on atherosclerotic risk profile and coronary artery disease angiographic severity","volume":"93","author":"Solymoss","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2014.04.009_bb0065","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1001\/jama.288.21.2709","article-title":"The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men","volume":"288","author":"Lakka","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2014.04.009_bb0070","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1161\/01.CIR.0000080897.52664.94","article-title":"Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study","volume":"108","author":"Sattar","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2014.04.009_bb0075","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1161\/01.CIR.0000140677.20606.0E","article-title":"Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults","volume":"110","author":"Malik","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2014.04.009_bb0080","doi-asserted-by":"crossref","first-page":"434","DOI":"10.2337\/diacare.16.2.434","article-title":"Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the multiple risk factor intervention trial","volume":"16","author":"Stamler","year":"1993","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ahj.2014.04.009_bb0085","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1161\/01.CIR.101.19.2231","article-title":"Prediction of 1-year survival after thrombolysis for acute myocardial infarction in the global utilization of streptokinase and TPA for occluded coronary arteries trial","volume":"101","author":"Califf","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2014.04.009_bb0090","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1161\/01.CIR.91.6.1659","article-title":"Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients","volume":"91","author":"Lee","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2014.04.009_bb0095","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.ahj.2006.12.018","article-title":"Documented traditional risk factors and mortality in patients with non\u2013ST-elevation myocardial infarction","volume":"153","author":"Roe","year":"2007","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2014.04.009_bb0100","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/eurheartj\/ehl329","article-title":"The impact of anthropomorphic indices on clinical outcomes in patients with acute ST elevation myocardial infarction","volume":"28","author":"Mehta","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2014.04.009_bb0105","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.amjmed.2010.07.028","article-title":"Race, bleeding and outcomes in patients with ST-elevation myocardial infarction treated with fibrinolytic therapy","volume":"124","author":"Mehta","year":"2011","journal-title":"Am J Med"},{"key":"10.1016\/j.ahj.2014.04.009_bb0110","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.ahj.2005.03.029","volume":"149","author":"Giugliano","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2014.04.009_bb0115","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1056\/NEJMoa0901316","article-title":"EARLY ACS Investigators. Early versus delayed, provisional eptifibatide in acute coronary syndromes","volume":"360","author":"Giugliano","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2014.04.009_bb0120","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2014.04.009_bb0125","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0140-6736(05)67402-8","article-title":"The metabolic syndrome\u2014a new worldwide definition","volume":"366","author":"Alberti","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2014.04.009_bb0130","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1001\/jama.284.7.835","article-title":"The TIMI risk score for unstable angina\/N-ST elevation MI: a method for prognostification and therapeutic decision making","volume":"284","author":"Antman","year":"2000","journal-title":"JAMA"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000287031400218X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000287031400218X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:51:18Z","timestamp":1757569878000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000287031400218X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S000287031400218X"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2014.04.009","relation":{},"ISSN":["0002-8703"],"issn-type":[{"type":"print","value":"0002-8703"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of metabolic syndrome and its individual components with outcomes among patients with high-risk non\u2013ST-segment elevation acute coronary syndromes","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2014.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}